[Clinical experience with loxaglat, a new contrast medium for angiography (author's transl)].
The dimer contrast-medium loxaglat was used in 150 subjects for aortic oder peripheral studies. Due to the localisation of the catheter a distinct reduction of side effects (burning sensation and pain reaction) was registered. Analgesic measures (general or spinal anaesthesia, intraarterial procaine or dilution of contrast media) was no longer needed.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000792:Angiography / Q000295:instrumentation*; D001027:Aortography / Q000295:instrumentation; D002445:Celiac Artery / Q000000981:diagnostic imaging; D002986:Clinical Trials as Topic; D005260:Female; D005263:Femoral Artery / Q000000981:diagnostic imaging; D006801:Humans; D007463:Iodobenzoates; D007485:Ioxaglic Acid; D007668:Kidney / Q000098:blood supply / Q000000981:diagnostic imaging; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D012077:Renal Artery / Q000000981:diagnostic imaging; D014283:Triiodobenzoic Acids
D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007485:Ioxaglic Acid
Klinische Erfahrungen mit Ioxaglat, einem neuen Kontrastmittel für die Angiographie.